0	1	A	a	DT
2	3	T	t	NN
4	17	cell-specific	cell-specific	JJ
18	26	enhancer	enhancer	NN
27	29	in	in	IN
30	33	the	the	DT
34	47	interleukin-3	interleukin-3	NN
48	53	locus	locus	NN
54	56	is	be	VBZ
57	66	activated	activate	VBN
67	80	cooperatively	cooperatively	RB
81	83	by	by	IN
84	87	Oct	Oct	NNP
88	91	and	and	CC
92	96	NFAT	NFAT	NNP
97	105	elements	element	NNS
106	112	within	within	IN
113	114	a	a	DT
115	120	DNase	DNase	NNP
121	137	I-hypersensitive	i-hypersensitive	JJ
138	142	site	site	NN
142	143	.	.	.

145	158	Interleukin-3	interleukin-3	NN
159	160	(	(	(
160	164	IL-3	IL-3	NNP
164	165	)	)	)
166	168	is	be	VBZ
169	170	a	a	DT
171	179	cytokine	cytokine	NN
180	184	that	that	WDT
185	187	is	be	VBZ
188	197	expressed	express	VBN
198	207	primarily	primarily	RB
208	210	in	in	IN
211	220	activated	activate	VBN
221	222	T	t	NN
223	228	cells	cell	NNS
228	229	.	.	.

230	234	Here	here	RB
235	237	we	we	PRP
238	248	identified	identify	VBD
249	251	an	an	DT
252	261	inducible	inducible	JJ
262	263	T	t	NN
264	277	cell-specific	cell-specific	JJ
278	286	enhancer	enhancer	NN
287	289	14	14	CD
290	292	kb	kb	NN
293	301	upstream	upstream	RB
302	304	of	of	IN
305	308	the	the	DT
309	313	IL-3	il-3	NN
314	318	gene	gene	NN
319	323	that	that	WDT
324	333	responded	respond	VBD
334	336	to	to	TO
337	347	activation	activation	NN
348	350	of	of	IN
351	352	T	t	NN
353	357	cell	cell	NN
358	366	receptor	receptor	NN
367	376	signaling	signaling	NN
377	385	pathways	pathway	NNS
385	386	.	.	.

387	390	The	the	DT
391	395	IL-3	il-3	NN
396	404	enhancer	enhancer	NN
405	412	spanned	span	VBD
413	415	an	an	DT
416	425	inducible	inducible	JJ
426	437	cyclosporin	cyclosporin	NN
438	449	A-sensitive	a-sensitive	JJ
450	455	DNase	DNase	NNP
456	472	I-hypersensitive	i-hypersensitive	JJ
473	477	site	site	NN
478	483	found	find	VBN
484	488	only	only	RB
489	491	in	in	IN
492	493	T	t	NN
494	499	cells	cell	NNS
499	500	.	.	.

501	505	Four	four	CD
506	515	NFAT-like	nfat-like	JJ
516	524	elements	element	NNS
525	530	exist	exist	VBP
531	537	within	within	IN
538	541	the	the	DT
542	550	enhancer	enhancer	NN
550	551	.	.	.

552	555	The	the	DT
556	559	two	two	CD
560	564	most	most	RBS
565	571	active	active	JJ
572	581	NFAT-like	nfat-like	JJ
582	590	elements	element	NNS
591	595	were	be	VBD
596	603	located	located	JJ
604	606	at	at	IN
607	610	the	the	DT
611	617	center	center	NN
618	620	of	of	IN
621	624	the	the	DT
625	630	DNase	DNase	NNP
631	647	I-hypersensitive	i-hypersensitive	JJ
648	652	site	site	NN
652	653	.	.	.

654	657	One	one	CD
658	660	of	of	IN
661	666	these	these	DT
667	676	NFAT-like	nfat-like	JJ
677	685	elements	element	NNS
686	697	encompassed	encompass	VBD
698	709	overlapping	overlap	VBG
710	714	Oct-	oct-	NN
715	718	and	and	CC
719	734	NFATp/c-binding	nfatp/c-binding	JJ
735	740	sites	site	NNS
740	741	,	,	,
742	747	which	which	WDT
748	758	functioned	function	VBD
759	761	in	in	IN
762	763	a	a	DT
764	770	highly	highly	RB
771	782	synergistic	synergistic	JJ
783	789	manner	manner	NN
789	790	.	.	.

791	793	We	we	PRP
794	801	suggest	suggest	VBP
802	806	that	that	IN
807	810	the	the	DT
811	812	T	t	NN
813	826	cell-specific	cell-specific	JJ
827	837	expression	expression	NN
838	840	of	of	IN
841	844	the	the	DT
845	849	IL-3	il-3	NN
850	854	gene	gene	NN
855	857	is	be	VBZ
858	864	partly	partly	RB
865	875	controlled	control	VBN
876	883	through	through	IN
884	887	the	the	DT
888	896	enhancer	enhancer	NN
897	899	by	by	IN
900	911	cooperation	cooperation	NN
912	919	between	between	IN
920	923	Oct	Oct	NNP
924	927	and	and	CC
928	932	NFAT	NFAT	NNP
933	939	family	family	NN
940	948	proteins	protein	NNS
948	949	.	.	.